CIK 0000880242 · Non-accelerated filer<br>Smaller reporting company
BIOLARGO, INC.
Sign in to watch- Ticker
- BLGO
- Exchange
- OTC
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650159115
- Phone
- 888 400-2863
- Business address
- 14921 CHESTNUT ST., WESTMINSTER, CA, 92683
- Former names
- NUWAY MEDICAL INC, NUWAY ENERGY INC, LATIN AMERICAN CASINOS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-03 | CALVERT DENNIS P President | Grant or award | +100,549 | $0.27 | $27K | 9,758,934 |
| 2022-10-03 | CODE KENNETH REAY Chief Science Officer | Grant or award | +167,781 | $0.27 | $45K | 24,871,660 |
| 2022-10-03 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +55,556 | 2,524,751 | ||
| 2022-10-03 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +55,556 | 2,477,251 | ||
| 2022-10-03 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +23,750 | 2,501,001 | ||
| 2022-10-03 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +69,444 | 2,831,201 | ||
| 2022-10-03 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +23,750 | 2,854,951 | ||
| 2022-10-03 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +69,444 | 3,594,729 | ||
| 2022-10-03 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +33,125 | 3,627,854 | ||
| 2022-07-07 | CALVERT DENNIS P President | Grant or award | +156,111 | $0.18 | $28K | 9,658,385 |
| 2022-06-30 | CODE KENNETH REAY Chief Science Officer | Grant or award | +107,784 | $0.18 | $19K | 24,703,879 |
| 2022-06-30 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +104,167 | 2,809,257 | ||
| 2022-06-30 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +150,000 | 4,236,500 | ||
| 2022-06-30 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +104,167 | 3,591,535 | ||
| 2022-06-30 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +83,333 | 1,345,704 | ||
| 2022-06-30 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +83,333 | 2,469,195 | ||
| 2022-03-31 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +65,217 | 2,385,862 | ||
| 2022-03-31 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +81,522 | 2,705,090 | ||
| 2022-03-31 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +65,217 | 1,262,371 | ||
| 2022-03-31 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +81,522 | 3,487,368 |
Page 6 of 12 · 228 trades